BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6132360)

  • 1. Chronic tyrosinemia associated with 4-hydroxyphenylpyruvate dioxygenase deficiency with acute intermittent ataxia and without visceral and bone involvement.
    Giardini O; Cantani A; Kennaway NG; D'Eufemia P
    Pediatr Res; 1983 Jan; 17(1):25-9. PubMed ID: 6132360
    [No Abstract]   [Full Text] [Related]  

  • 2. A new variant form of hypertyrosinaemia due to 4-hydroxyphenylpyruvic acid oxidase deficiency.
    Endo F; Kitano A; Uehara I; Nagata N; Matsuda I; Shinka T; Kuhara T; Matsumoto I
    J Inherit Metab Dis; 1982; 5(4):237-8. PubMed ID: 6133038
    [No Abstract]   [Full Text] [Related]  

  • 3. Enzyme defect in a case of tyrosinemia type I, acute form.
    Furukawa N; Kinugasa A; Seo T; Ishii T; Ota T; Machida Y; Inoue F; Imashuku S; Kusunoki T; Takamatsu T
    Pediatr Res; 1984 May; 18(5):463-6. PubMed ID: 6145143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hereditary tyrosinemia: examination of the liver by electron microscopy of hepatic biopsies: observation of 7 cases].
    Tremblay M; Bélanger L; Larochelle J; Privé L; Gagnon PM
    Union Med Can; 1977 Jul; 106(7):1014-6. PubMed ID: 898402
    [No Abstract]   [Full Text] [Related]  

  • 5. Dietary treatment of tyrosinemia type I: importance of methionine restriction.
    Michals K; Matolon R; Wong PW
    J Am Diet Assoc; 1978 Nov; 73(5):507-14. PubMed ID: 701680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four-hydroxyphenylpyruvic acid oxidase deficiency with normal fumarylacetoacetase: a new variant form of hereditary hypertyrosinemia.
    Endo F; Kitano A; Uehara I; Nagata N; Matsuda I; Shinka T; Kuhara T; Matsumoto I
    Pediatr Res; 1983 Feb; 17(2):92-6. PubMed ID: 6828337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of tyrosine aminotransferase and para-hydroxyphenylpyruvate dioxygenase activities in fetal and neonatal human liver.
    Ohisalo JJ; Laskowska-Klita T; Andersson SM
    J Clin Invest; 1982 Jul; 70(1):198-200. PubMed ID: 6123525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association, in the same subject, of deletion of the short arm of chromosome 4 (4p-) and of complete deficiency of parahydroxyphenyl-pyruvate oxidase activity in the liver (tyrosinosis)].
    Malpuech G; Mattei JF; Gaulme J; Palcoux JB; Lesec G; Vanlieferinghen P
    J Genet Hum; 1981 Dec; 29(4):455-61. PubMed ID: 7328420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary p-tyramine in hereditary tyrosinemia: I. Levels as compared to normal individuals, effect of diet, and relationship to urinary tyrosine.
    Hoag GN; Hill A; Zaleski W
    Clin Biochem; 1977 Feb; 10(1):24-5. PubMed ID: 837522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excretion of cis- and trans-4-hydroxycyclohexylacetic acid in addition to hawkinsin in a family with a postulated defect of 4-hydroxyphenylpyruvate dioxygenase.
    Niederwieser A; Wadman SK; Danks DM
    Clin Chim Acta; 1978 Dec; 90(2):195-200. PubMed ID: 719903
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatic tyrosine aminotransferase in tyrosinaemia type II.
    Kida K; Takahashi M; Fujisawa Y; Matsuda H; Machino H; Miki Y
    J Inherit Metab Dis; 1982; 5(4):229-30. PubMed ID: 6133036
    [No Abstract]   [Full Text] [Related]  

  • 12. Tyrosinosis (tyrosinaemia).
    Jaiswal RB
    Indian Pediatr; 1975 Mar; 12(3):209-10. PubMed ID: 239906
    [No Abstract]   [Full Text] [Related]  

  • 13. Tyrosinemia type III: diagnosis and ten-year follow-up.
    Cerone R; Holme E; Schiaffino MC; Caruso U; Maritano L; Romano C
    Acta Paediatr; 1997 Sep; 86(9):1013-5. PubMed ID: 9343288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parahydroxyphenylpyruvicacidemia in tyrosinosis.
    Jaiswal RB; Bhai I; Daginawala HF; Nath N; Nath MC
    Indian Pediatr; 1978 Nov; 15(11):893-9. PubMed ID: 36347
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative studies in vivo and in vitro of rat-liver enzymes.
    Salinas M; Wallace R; Grisolia S
    Eur J Biochem; 1974 May; 44(2):375-81. PubMed ID: 4151857
    [No Abstract]   [Full Text] [Related]  

  • 16. The enzymatic deficiency in tyrosinemia.
    La Du BN
    Am J Dis Child; 1967 Jan; 113(1):54-7. PubMed ID: 4380967
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary p-tyramine in hereditary tyrosinemia: II. Origin of urinary p-tyramine.
    Hoag GN; Hill A; Zaleski W
    Clin Biochem; 1977 Feb; 10(1):26-8. PubMed ID: 837523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary excretion of deuterated metabolites in patients with tyrosinemia type I after oral loading with deuterated L-tyrosine.
    Wadman SK; Duran M; Ketting D; Bruinvis L; van Sprang FJ; Berger R; Smit GP; Steinmann B; Leonard JV; Divry P; Farriaux JP; Cartigny B
    Clin Chim Acta; 1983 May; 130(2):231-8. PubMed ID: 6872257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hereditary tyrosinemia type III].
    Endo F
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):137-40. PubMed ID: 9590008
    [No Abstract]   [Full Text] [Related]  

  • 20. Putative genetic deficiency of 4-hydroxyphenylpyruvic acid dioxygenase in mice: a murine model for hereditary tyrosinaemia type III.
    Endo F; Katoh H; Matsuda I
    J Inherit Metab Dis; 1990; 13(5):780-2. PubMed ID: 2246865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.